SuperArray Licenses RNAi IP from Carnegie Institution | GenomeWeb
NEW YORK (GenomeWeb News) – SuperArray Bioscience has licensed gene-silencing intellectual property from the Carnegie Institution, the firm said today.
 
SuperArray will use Carnegie’s technology to offer RNAi-based gene silencing products for studies including gene-specific siRNA and DNA-based RNAi expressing short hairpin RNA. It also has the right to pass on the technology to end users performing DNA-based RNA interference, said SuperArray.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.